Research Library

Nonresident scholar Kevin Erickson is a co-author of a study that examined trends in employment among patients initiating dialysis and in the six months before end stage renal disease.

The authors compare views on the relationship between faith and health for two groups that are overrepresented in American Christianity and underrepresented in medical careers (African Americans and Latinos) with a group that is similarly religious but comparatively well-represented in medical professions (Korean Americans).

The authors examine adherence to treatment guidelines for colon cancer among elderly patients in Texas.

Insurers and physicians can partner to deliver care more efficiently and save costs, according to a study that examined Cigna’s Collaborative Accountable Care initiative’s partnership with the Medical Clinic of North Texas.

As Zika virus infection spreads across the Latin American and Caribbean region and into the southern United States, we can expect to see thousands of additional children born with microcephaly and more newborns or older infants with signs of more subtle but significant neurologic defects and developmental delays.

The Medicare program’s transition in 2004 to tiered fee-for-service physician reimbursement for dialysis care had the unintended consequence of reducing use of home dialysis. In this paper, authors evaluate whether payment reform influenced dialysis modality assignment.

Current medical research and literature may be overemphasizing the role that hospital volume plays in patient outcomes, according to a study co-authored by health economics fellow Vivian Ho.

This journal article examines the risks patients face in seeking experimental stem cell-based interventions from clinics outside the United States. The authors advocate for new public policies that encourage patients to remain in clinical trials in the U.S.

While the Food and Drug Administration currently regulates storage and use of cord blood (CB) in the United States, other state and federal guidelines on CB education, awareness and ethical considerations remain variable, and no mandatory international guidelines exist. To help organize and coordinate efforts across the United States and other nations, policymakers should implement regulations for high quality standards for both private and public CB banks.

Regenerative medicine and stem cell research are exciting new fields. But as the fields progress toward clinical therapies, controversies emerge. Hype surrounding stem cell research has caused an increase in their use in interventions that are not clinically proven. Furthermore, the regulatory agencies have a lot of difficulty dealing with cell therapies, which are distinctly different from drugs and medical devices they more commonly approve. To move the field forward, advocates, regulators and scientists need to come together to find new options for stem cell research oversight that protects both the patients and the research field.